CLDX
Price
$21.35
Change
+$1.82 (+9.32%)
Updated
Jun 6 closing price
Capitalization
1.3B
59 days until earnings call
MLTX
Price
$46.88
Change
-$1.95 (-3.99%)
Updated
Jun 6 closing price
Capitalization
3.1B
59 days until earnings call
Interact to see
Advertisement

CLDX vs MLTX

Header iconCLDX vs MLTX Comparison
Open Charts CLDX vs MLTXBanner chart's image
Celldex Therapeutics
Price$21.35
Change+$1.82 (+9.32%)
Volume$852.59K
Capitalization1.3B
MoonLake Immunotherapeutics
Price$46.88
Change-$1.95 (-3.99%)
Volume$881.42K
Capitalization3.1B
CLDX vs MLTX Comparison Chart
Loading...
CLDX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MLTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CLDX vs. MLTX commentary
Jun 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CLDX is a StrongBuy and MLTX is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 09, 2025
Stock price -- (CLDX: $18.66 vs. MLTX: $38.17)
Brand notoriety: CLDX and MLTX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CLDX: 127% vs. MLTX: 52%
Market capitalization -- CLDX: $1.3B vs. MLTX: $3.1B
CLDX [@Biotechnology] is valued at $1.3B. MLTX’s [@Biotechnology] market capitalization is $3.1B. The market cap for tickers in the [@Biotechnology] industry ranges from $323.27B to $0. The average market capitalization across the [@Biotechnology] industry is $2.25B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CLDX’s FA Score shows that 0 FA rating(s) are green whileMLTX’s FA Score has 0 green FA rating(s).

  • CLDX’s FA Score: 0 green, 5 red.
  • MLTX’s FA Score: 0 green, 5 red.
According to our system of comparison, CLDX is a better buy in the long-term than MLTX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CLDX’s TA Score shows that 3 TA indicator(s) are bullish while MLTX’s TA Score has 3 bullish TA indicator(s).

  • CLDX’s TA Score: 3 bullish, 6 bearish.
  • MLTX’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, MLTX is a better buy in the short-term than CLDX.

Price Growth

CLDX (@Biotechnology) experienced а -6.47% price change this week, while MLTX (@Biotechnology) price change was -0.96% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.11%. For the same industry, the average monthly price growth was +10.01%, and the average quarterly price growth was -2.16%.

Reported Earning Dates

CLDX is expected to report earnings on Aug 07, 2025.

MLTX is expected to report earnings on Aug 07, 2025.

Industries' Descriptions

@Biotechnology (+4.11% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MLTX($3.1B) has a higher market cap than CLDX($1.3B). CLDX YTD gains are higher at: -26.158 vs. MLTX (-29.511). MLTX has higher annual earnings (EBITDA): -141.71M vs. CLDX (-191.9M). CLDX has more cash in the bank: 725M vs. MLTX (448M). MLTX has less debt than CLDX: MLTX (2.83M) vs CLDX (3.81M). CLDX has higher revenues than MLTX: CLDX (7.02M) vs MLTX (0).
CLDXMLTXCLDX / MLTX
Capitalization1.3B3.1B42%
EBITDA-191.9M-141.71M135%
Gain YTD-26.158-29.51189%
P/E RatioN/AN/A-
Revenue7.02M0-
Total Cash725M448M162%
Total Debt3.81M2.83M135%
FUNDAMENTALS RATINGS
CLDX: Fundamental Ratings
CLDX
OUTLOOK RATING
1..100
3
VALUATION
overvalued / fair valued / undervalued
1..100
55
Fair valued
PROFIT vs RISK RATING
1..100
67
SMR RATING
1..100
96
PRICE GROWTH RATING
1..100
63
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CLDXMLTX
RSI
ODDS (%)
Bearish Trend 12 days ago
85%
N/A
Stochastic
ODDS (%)
Bearish Trend 12 days ago
86%
Bullish Trend 12 days ago
67%
Momentum
ODDS (%)
Bearish Trend 12 days ago
81%
Bearish Trend 12 days ago
52%
MACD
ODDS (%)
Bearish Trend 12 days ago
86%
Bearish Trend 12 days ago
58%
TrendWeek
ODDS (%)
Bearish Trend 12 days ago
84%
Bearish Trend 12 days ago
59%
TrendMonth
ODDS (%)
Bearish Trend 12 days ago
83%
Bearish Trend 12 days ago
58%
Advances
ODDS (%)
Bullish Trend 21 days ago
82%
Bullish Trend 20 days ago
81%
Declines
ODDS (%)
Bearish Trend 12 days ago
81%
Bearish Trend 12 days ago
73%
BollingerBands
ODDS (%)
N/A
N/A
Aroon
ODDS (%)
Bullish Trend 12 days ago
75%
Bullish Trend 12 days ago
78%
View a ticker or compare two or three
Interact to see
Advertisement
CLDX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MLTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AAPL200.420.21
+0.10%
Apple
SPY587.73-3.42
-0.58%
SPDR® S&P 500® ETF
BTC.X107802.330000-1192.312500
-1.09%
Bitcoin cryptocurrency
TSLA356.90-5.99
-1.65%
Tesla
GME31.21-3.80
-10.85%
GameStop Corp

CLDX and

Correlation & Price change

A.I.dvisor indicates that over the last year, CLDX has been loosely correlated with DNLI. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if CLDX jumps, then DNLI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CLDX
1D Price
Change %
CLDX100%
-5.66%
DNLI - CLDX
53%
Loosely correlated
-1.29%
BEAM - CLDX
53%
Loosely correlated
-0.88%
KYMR - CLDX
52%
Loosely correlated
+2.35%
RVMD - CLDX
49%
Loosely correlated
+2.04%
NTLA - CLDX
49%
Loosely correlated
+3.59%
More

MLTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, MLTX has been loosely correlated with XENE. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if MLTX jumps, then XENE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MLTX
1D Price
Change %
MLTX100%
-1.06%
XENE - MLTX
46%
Loosely correlated
-3.29%
CLDX - MLTX
46%
Loosely correlated
-5.66%
DNLI - MLTX
46%
Loosely correlated
-1.29%
IDYA - MLTX
45%
Loosely correlated
+0.72%
NTLA - MLTX
45%
Loosely correlated
+3.59%
More